PAKOLA STEVE — SEC Form 4 filings
SEC reporting owner CIK 1700659. 12 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-07 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 91,805 shares, $1,305,191 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 36,725 shares @ $12.86 ($472,284) in REGENXBIO Inc., filed 2026-07-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | Chief Medical Officer | 12 | — | 6 legs · 91,805 sh · $1,305,191 | 16 |
Form 4 filings — PAKOLA STEVE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 7,468 @ $9.69 | EDGAR |
| 2026-07-06 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 2,161 @ $7.86 · Sale (S): 2,161 @ $13.64 · Option exercise (M): 2,161 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 19,608 @ $11.04 · Option exercise (M): 36,725 @ $7.86 · Sale (S): 36,725 @ $12.86 · Option exercise (M): 36,725 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 15,309 @ $11.02 | EDGAR |
| 2026-03-12 | 4 | REGENXBIO Inc. (RGNX) | Sale (S): 5,124 @ $10.35 | EDGAR |
| 2026-02-03 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 5,267 @ $11.16 | EDGAR |
| 2026-01-08 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 65,847 @ $0 · Grant/award (A): 35,402 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 18,247 @ $14.40 | EDGAR |
| 2025-04-04 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 5,263 @ $8.07 | EDGAR |
| 2025-01-06 | 4 | REGENXBIO Inc. (RGNX) | Tax withholding (F): 13,891 @ $7.73 · Grant/award (A): 64,293 @ $0 · Grant/award (A): 103,698 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 58,386 @ $0 | EDGAR |
| 2024-03-07 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 12,878 @ $22.25 · Sale (S): 12,878 @ $28.36 · Option exercise (M): 12,878 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1700659 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →